CVS Health (MEX:CVS) Cyclically Adjusted Revenue per Share: MXN4,799.14 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CVS CVS Health Corp MEX:CVS
70 GF Score
Price MXN1,840.00
GF Value MXN1,346.47
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is CVS Health Cyclically Adjusted Revenue per Share?

CVS Health MEX:CVS -0.27% 70 Cyclically Adjusted Revenue per Share is MXN4,799.14 as of Mar. 2026. GuruFocus rates MEX:CVS with a GF Score™ of 70/100 and a GF Value™ of MXN1,346.47 (Significantly Overvalued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

CVS Health's adjusted revenue per share for the three months ended in Mar. 2026 was MXN1,415.912. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN4,799.14 for the trailing ten years ended in Mar. 2026.

During the past 12 months, CVS Health's average Cyclically Adjusted Revenue Growth Rate was 8.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 11.00% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of CVS Health was 13.20% per year. The lowest was 1.30% per year. And the median was 11.00% per year.

As of today (2026-07-15), CVS Health's current stock price is MXN1840.00. CVS Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was MXN4,799.14. CVS Health's Cyclically Adjusted PS Ratio of today is 0.38.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CVS Health was 1.03. The lowest was 0.18. And the median was 0.46.


CVS Health  (MEX:CVS) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

CVS Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1840.00/4799.14
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of CVS Health was 1.03. The lowest was 0.18. And the median was 0.46.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


CVS Health Cyclically Adjusted Revenue per Share Related Terms


CVS Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for CVS Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVS Health Cyclically Adjusted Revenue per Share Chart

CVS Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,686.68 3,841.67 3,803.21 5,072.06 4,758.92

CVS Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,168.38 4,800.41 4,804.65 4,758.92 4,799.14

MEX:CVS vs ELV, CI, HUM: Cyclically Adjusted Revenue per Share Comparison

For the Healthcare Plans subindustry, CVS Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CVS Health Cyclically Adjusted PS Ratio vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, CVS Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CVS Health's Cyclically Adjusted PS Ratio falls into.


MEX:CVS
70GF Score
CVS Health Corp MEX:CVS
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CVS Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CVS Health's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1415.912/330.2130*330.2130
=1,415.912

Current CPI (Mar. 2026) = 330.2130.

CVS Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 752.212 241.018 1,030.588
201609 803.964 241.428 1,099.621
201612 886.165 241.432 1,212.032
201703 809.811 243.801 1,096.838
201706 806.447 244.955 1,087.136
201709 821.660 246.819 1,099.278
201712 933.860 246.524 1,250.883
201803 815.545 249.554 1,079.139
201806 905.691 251.989 1,186.841
201809 869.179 252.439 1,136.965
201812 952.420 251.233 1,251.832
201903 918.440 254.202 1,193.070
201906 935.822 256.143 1,206.438
201909 980.444 256.759 1,260.931
201912 962.263 256.974 1,236.513
202003 1,193.042 258.115 1,526.289
202006 1,147.799 257.797 1,470.219
202009 1,126.490 260.280 1,429.160
202012 1,052.944 260.474 1,334.858
202103 1,068.390 264.877 1,331.925
202106 1,089.295 271.696 1,323.904
202109 1,141.725 274.310 1,374.403
202112 1,174.480 278.802 1,391.054
202203 1,151.869 287.504 1,322.980
202206 1,228.036 296.311 1,368.540
202209 1,241.455 296.808 1,381.178
202212 1,238.380 296.797 1,377.808
202303 1,190.655 301.836 1,302.594
202306 1,184.501 305.109 1,281.960
202309 1,212.085 307.789 1,300.392
202312 1,231.558 306.746 1,325.776
202403 1,158.424 312.332 1,224.744
202406 1,327.574 314.175 1,395.344
202409 1,492.459 315.301 1,563.044
202412 1,614.747 315.605 1,689.487
202503 1,530.934 319.799 1,580.788
202506 1,466.528 322.561 1,501.318
202509 1,487.066 324.800 1,511.849
202512 1,479.842 324.054 1,507.968
202603 1,415.912 330.213 1,415.912

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN4,799.14 mean?
CVS Health (MEX:CVS) has a Cyclically Adjusted Revenue per Share of MXN4,799.14 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on CVS Health and its competitors.
Is CVS Health's Cyclically Adjusted Revenue per Share too high?
CVS Health's current Cyclically Adjusted Revenue per Share is MXN4,799.14. Overall, CVS Health has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CVS Health's Cyclically Adjusted Revenue per Share compare to ELV and CI?
CVS Health's Cyclically Adjusted Revenue per Share of MXN4,799.14 can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Plans company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Plans industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on CVS Health and its competitors. CVS Health's current Cyclically Adjusted Revenue per Share is MXN4,799.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Health stock overvalued right now?
Based on GuruFocus' analysis, CVS Health (MEX:CVS) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN1,346.47, compared to a current price of MXN1,840.00 — trading 36.7% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN4,799.14. CVS Health's overall GF Score™ is 70/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For CVS Health (MEX:CVS), the current Cyclically Adjusted Revenue per Share is MXN4,799.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CVS Health (MEX:CVS) Overvalued in 2026?

Based on GuruFocus' analysis, CVS Health stock appears to be overvalued. The current stock price of MXN1,840.00 is trading 36.7% above its estimated GF Value™ of MXN1,346.47. GuruFocus considers CVS Health to be Significantly Overvalued.

Key valuation signals for MEX:CVS:

  • Cyclically Adjusted Revenue per Share: MXN4,799.14
  • GF Value™: MXN1,346.47 vs. price of MXN1,840.00 (36.7% above fair value)
  • GF Score™: 70/100 with 10 warning signs

No single metric tells the full story. See the MEX:CVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CVS Health Business Description

Address One CVS Drive, Woonsocket, RI, USA, 02895
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
70GF Score

Get the complete analysis for MEX:CVS

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,840.00
Price
MXN1,346.47
GF Value